Stock IMNN IMUNON, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Imunon, Inc.

Equities

IMNN

US15117N6022

Market Closed - Nasdaq
Other stock markets
 02:00:01 03/05/2024 am IST 		5-day change 1st Jan Change
1.31 USD 0.00% Intraday chart for Imunon, Inc. +0.77% +92.65%
18/04 Imunon Receives FDA Approval to Start Phase 1 Trial of COVID-19 Booster Vaccine MT
18/04 Imunon Shares Rise 8% After Clearance to Start Phase 1 Trial for Covid-19 Booster Vaccine DJ

Evolution of the average Target Price on Imunon, Inc.

Price target over the last 5 years

History of analyst recommendation changes

9c4d9eab97e9f3e46ad461e03f6193a.nnwFmMRo1T4RPld-k8YH0Ux8bSr-4ME1rHEjrXBzgzM.7xNwzq0Pnl9LZ2Ub3_Vesnw-PEyuibVP5UJ7wzFEylbuHV3X8wy0cyVUAg~e5097ae04bf086c78e492e63d7274001

Analyst Recommendations on Imunon, Inc.

HC Wainwright Adjust Price Target on Imunon to $13 From $12, Keeps Buy Rating MT
Alliance Global Starts Imunon at Buy with $15 Price Target MT
HC Wainwright Starts Celsion at Buy With $16 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.31 USD
Average target price
12 USD
Spread / Average Target
+816.03%
High Price Target
15 USD
Spread / Highest target
+1,045.04%
Low Price Target
8 USD
Spread / Lowest Target
+510.69%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Imunon, Inc.

HC Wainwright
Alliance Global Partners

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. IMNN Stock
  4. Consensus Imunon, Inc.